Mergers and Acquisitions
Our market leading M&A practice works on some of the most innovative and ground-breaking transactions in both the public and private M&A sector.
We have diverse expertise across a range of industries including the resources and renewables, food and agribusiness, technology, media and telecommunications, life sciences, tourism, financial services, and fintech industries.
Our industry focused M&A team collaborates seamlessly with subject matter experts on technical issues, including tax, regulatory (including foreign investment), property, environment and planning, project approvals, employment relations and safety, intellectual property, and technology.
We project manage transactions from beginning to end, identifying the key components of the transaction, and meticulously managing execution.
We also routinely work with international investors seeking opportunities in Australia, particularly investors from Japan, U.S, New Zealand, Germany, and the United Kingdom.
Our services include:
- public M&A including takeovers and schemes of arrangement;
- cross border transactions;
- investments;
- divestments;
- joint ventures, partnerships and limited partnerships;
- private equity;
- corporate restructures;
- recapitalisation;
- foreign investment;
- due diligence;
- not-for-profit mergers and collaboration;
- merger clearance; and
- service and supply arrangements.
To read our latest insights, click here.
Experience
New Hope Corporation
Advising on the acquisition of an 80 percent interest in the Bengalla Joint Venture for $1.75 billion from Rio Tinto, Wesfarmers, and Mitsui. Also advising on the acquisition of the Burton Mine and related infrastructure to the Lenton Joint Venture.
New Hope Corporation Limited reached a binding commitment with Wesfarmers Limited to purchase a further 40 percent interest in the Bengalla Joint Venture for $860 million.
Viralytics Limited
Advising on its acquisition by Merck & Co, known as Merck Sharp and Dohme outside of North America. This transaction “carries the greatest sum ever offered for a local drug developer in the commercial history of Australian biotech.
Mackay Sugar Limited
Advising on a recapitalisation and investment by German sugar manufacturer, Nordzucker AG. Nordzucker AG acquired a 70 percent controlling interest in the share capital of Mackay Sugar through an investment of equity and debt of $120 million. Also advising Mackay Sugar on the refinancing of its existing $200+ million senior debt with Rabobank and NAB.
Gallagher Bassett Services
Advising on its acquisition of Fullerton Health Corporate Services from Fullerton Health Australia, part of the Singapore based Fullerton Healthcare Group, growing Gallagher Bassett to the largest claims provider of accident health in Australia.
Over the Wire Holdings
Advising on a capital raising and double acquisition of Access Digital Networks and Comlinx. The simultaneous execution of this deal involved a high degree of collaboration between the McCullough Robertson team, OTW’s management, and counter-parties. OTW agreed to acquire the two targets for $34.5 million.
Sojitz Corporation
Advising international client, Sojitz, on the acquisition of the Gregory Crinum Coalmine, including negotiating the transaction and funding documents.
River City Labs
Advising on the sale of startup accelerator River City Labs to the ICT professional association, Australian Computer Society (ACS). River City Labs Group fosters the growth of tech startups and scale-ups in Queensland. The sale also includes Startup Catalyst, which conducts missions to Silicon Valley and other international startup hotspots.
Other Levels Holdings Limited
Advising on its acquisition of the digital media business conducted by XCOM Media Pty Ltd.
DoseMe Holdings Pty Ltd
Advising DoseMe US tax and legal teams to provide advice to the company and its Australian shareholders with respect to the negotiation and sale of shares to TabulaRasa Healthcare, a company listed on the NASDAQ.